{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:41:51Z","timestamp":1707525711583},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,21]]},"DOI":"10.7759\/cureus.52692","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T05:55:16Z","timestamp":1705902916000},"source":"Crossref","is-referenced-by-count":0,"title":["Descriptive Characteristics of Multiple Myeloma Patients in King Abdulaziz Medical City National Guard"],"prefix":"10.7759","author":[{"given":"Sultan","family":"Alqahtani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lama","family":"Alyabis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hissah","family":"Alyabis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nouf","family":"Al Qurashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Almadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majd","family":"Alsoman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0018-y","article-title":"The multiple myelomas - current concepts in cytogenetic classification and therapy","volume":"15","author":"Kumar SK","year":"2018","unstructured":"Kumar SK, Rajkumar SV. The multiple myelomas - current concepts in cytogenetic classification and therapy. Nat Rev Clin Oncol. 2018, 15:409-21. 10.1038\/s41571-018-0018-y","journal-title":"Nat Rev Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2012.11.003","article-title":"Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life","volume":"46","author":"Boland E","year":"2013","unstructured":"Boland E, Eiser C, Ezaydi Y, Greenfield DM, Ahmedzai SH, Snowden JA. Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life. J Pain Symptom Manage. 2013, 46:671-80. 10.1016\/j.jpainsymman.2012.11.003","journal-title":"J Pain Symptom Manage"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12790","article-title":"Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis","volume":"97","author":"Ramsenthaler C","year":"2016","unstructured":"Ramsenthaler C, Kane P, Gao W, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ. Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis. Eur J Haematol. 2016, 97:416-29. 10.1111\/ejh.12790","journal-title":"Eur J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4065\/79.7.859","article-title":"Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later","volume":"79","author":"Kyle RA","year":"2004","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Melton LJ 3rd. Long-term follow-up of 241 patients with monoclonal gammopathy of undetermined significance: the original Mayo Clinic series 25 years later. Mayo Clin Proc. 2004, 79:859-66. 10.4065\/79.7.859","journal-title":"Mayo Clin Proc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: a unique malignancy","volume":"43","author":"Kazandjian D","year":"2016","unstructured":"Kazandjian D. Multiple myeloma epidemiology and survival: a unique malignancy. Semin Oncol. 2016, 43:676-81. 10.1053\/j.seminoncol.2016.11.004","journal-title":"Semin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren O","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, et al.. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009, 113:5412-7. 10.1182\/blood-2008-12-194241","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22718","article-title":"Multiple myeloma: a review of the epidemiologic literature","volume":"120 Suppl 12","author":"Alexander DD","year":"2007","unstructured":"Alexander DD, Mink PJ, Adami HO, Cole P, Mandel JS, Oken MM, Trichopoulos D. Multiple myeloma: a review of the epidemiologic literature. Int J Cancer. 2007, 120 Suppl 12:40-61. 10.1002\/ijc.22718","journal-title":"Int J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1849-3","article-title":"Multiple myeloma: a descriptive study of 217 Egyptian patients","volume":"93","author":"El Husseiny NM","year":"2014","unstructured":"El Husseiny NM, Kasem N, El Azeeim HA, Mattar MW. Multiple myeloma: a descriptive study of 217 Egyptian patients. Ann Hematol. 2014, 93:141-5. 10.1007\/s00277-013-1849-3","journal-title":"Ann Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-85772-3_2","article-title":"Epidemiology of multiple myeloma","volume":"183","author":"Becker N","year":"2011","unstructured":"Becker N. Epidemiology of multiple myeloma. Recent Results Cancer Res. 2011, 183:25-35. 10.1007\/978-3-540-85772-3_2","journal-title":"Recent Results Cancer Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/10245332.2017.1309493","article-title":"Analysis of clinical characteristics and prognostic factors of multiple myeloma: a retrospective single-center study of 787 cases","volume":"22","author":"Qian J","year":"2017","unstructured":"Qian J, Jin J, Luo H, Jin C, Wang L, Qian W, Meng H. Analysis of clinical characteristics and prognostic factors of multiple myeloma: a retrospective single-center study of 787 cases. Hematology. 2017, 22:472-6. 10.1080\/10245332.2017.1309493","journal-title":"Hematology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2016.0470","article-title":"The diagnosis and treatment of multiple myeloma","volume":"113","author":"Gerecke C","year":"2016","unstructured":"Gerecke C, Fuhrmann S, Strifler S, Schmidt-Hieber M, Einsele H, Knop S. The diagnosis and treatment of multiple myeloma. Dtsch Arztebl Int. 2016, 113:470-6. 10.3238\/arztebl.2016.0470","journal-title":"Dtsch Arztebl Int"},{"key":"ref12","unstructured":"IBM Corp.  IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY. IBM Corp. (2013). Accessed: February 20, 2021: https:\/\/www.ibm.com\/support\/pages\/downloading-ibm-spss-statistics-20."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21357","article-title":"2016 US lymphoid malignancy statistics by World Health Organization subtypes","volume":"66","author":"Teras LR","year":"2016","unstructured":"Teras LR, DeSantis CE, Cerhan JR, Morton LM, Jemal A, Flowers CR. 2016 US lymphoid malignancy statistics by World Health Organization subtypes. CA Cancer J Clin. 2016, 66:443-59. 10.3322\/caac.21357","journal-title":"CA Cancer J Clin"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple myeloma","volume":"364","author":"Palumbo A","year":"2011","unstructured":"Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011, 364:1046-60. 10.1056\/NEJMra1011442","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.107714","article-title":"Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients","volume":"100","author":"Blimark C","year":"2015","unstructured":"Blimark C, Holmberg E, Mellqvist UH, et al.. Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients. Haematologica. 2015, 100:107-13. 10.3324\/haematol.2014.107714","journal-title":"Haematologica"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-44554","article-title":"Hyperviscosity syndrome in plasma cell dyscrasias","volume":"29","author":"Mehta J","year":"2003","unstructured":"Mehta J, Singhal S. Hyperviscosity syndrome in plasma cell dyscrasias. Semin Thromb Hemost. 2003, 29:467-71. 10.1055\/s-2003-44554","journal-title":"Semin Thromb Hemost"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2015.07.005","article-title":"Clinical characteristics of patients with relapsed multiple myeloma","volume":"41","author":"Dimopoulos MA","year":"2015","unstructured":"Dimopoulos MA, Terpos E, Niesvizky R, Palumbo A. Clinical characteristics of patients with relapsed multiple myeloma. Cancer Treat Rev. 2015, 41:827-35. 10.1016\/j.ctrv.2015.07.005","journal-title":"Cancer Treat Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle RA","year":"2003","unstructured":"Kyle RA, Gertz MA, Witzig TE, et al.. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003, 78:21-33. 10.4065\/78.1.21","journal-title":"Mayo Clin Proc"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"International Myeloma Working Group","year":"2003","unstructured":"International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003, 121:749-57.","journal-title":"Br J Haematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008953","article-title":"A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy","volume":"7","author":"Kleman A","year":"2023","unstructured":"Kleman A, Singavi A, Pommert L, et al.. A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy. Blood Adv. 2023, 7:5549-53. 10.1182\/bloodadvances.2022008953","journal-title":"Blood Adv"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(05)70151-3","article-title":"Infections in multiple myeloma","volume":"15","author":"Paradisi F","year":"2001","unstructured":"Paradisi F, Corti G, Cinelli R. Infections in multiple myeloma. Infectious Disease Clinics. 2001, 15:373-84. 10.1016\/S0891-5520(05)70151-3","journal-title":"Infectious Disease Clinics"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.231513","article-title":"IgA type multiple myeloma, clinical features, and prognosis","volume":"131","author":"Wang L","year":"2018","unstructured":"Wang L, Jin FY, Li Y, Sun JN, Zhang JJ, Tang R, Zhong YP. IgA type multiple myeloma, clinical features, and prognosis. Chin Med J (Engl). 2018, 131:1249-50. 10.4103\/0366-6999.231513","journal-title":"Chin Med J (Engl)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14513","article-title":"Multiple myeloma: routes to diagnosis, clinical characteristics and survival - findings from a UK population-based study","volume":"177","author":"Howell D","year":"2017","unstructured":"Howell D, Smith A, Appleton S, et al.. Multiple myeloma: routes to diagnosis, clinical characteristics and survival - findings from a UK population-based study. Br J Haematol. 2017, 177:67-71. 10.1111\/bjh.14513","journal-title":"Br J Haematol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08573.x","article-title":"Guidelines for the diagnosis and management of multiple myeloma 2011","volume":"154","author":"Bird JM","year":"2011","unstructured":"Bird JM, Owen RG, D'Sa S, et al.. Guidelines for the diagnosis and management of multiple myeloma 2011. Br J Haematol. 2011, 154:32-75. 10.1111\/j.1365-2141.2011.08573.x","journal-title":"Br J Haematol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.157327","article-title":"Renal failure in patients with multiple myeloma","volume":"26","author":"Almueilo SH","year":"2015","unstructured":"Almueilo SH. Renal failure in patients with multiple myeloma. Saudi J Kidney Dis Transpl. 2015, 26:482-8. 10.4103\/1319-2442.157327","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.1991.642","article-title":"Multiple myeloma: a review of 92 cases at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia","volume":"11","author":"Khalil SH","year":"1991","unstructured":"Khalil SH, Padmos A, Ernst P, Clink HM. Multiple myeloma: a review of 92 cases at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Ann Saudi Med. 1991, 11:642-6. 10.5144\/0256-4947.1991.642","journal-title":"Ann Saudi Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.patbio.2004.01.014","article-title":"[Monoclonal gammapathies in Tunisia: epidemiological, immunochemical and etiological analysis of 288 cases]","volume":"53","author":"Mseddi-Hdiji S","year":"2005","unstructured":"Mseddi-Hdiji S, Haddouk S, Ben Ayed M, et al.. [Monoclonal gammapathies in Tunisia: epidemiological, immunochemical and etiological analysis of 288 cases]. Pathol Biol (Paris). 2005, 53:19-25. 10.1016\/j.patbio.2004.01.014","journal-title":"Pathol Biol (Paris)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3816\/CLML.2010.n.080","article-title":"Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple myeloma","volume":"10","author":"Talamo G","year":"2010","unstructured":"Talamo G, Farooq U, Zangari M, Liao J, Dolloff NG, Loughran TP Jr, Epner E. Beyond the CRAB symptoms: a study of presenting clinical manifestations of multiple myeloma. Clin Lymphoma Myeloma Leuk. 2010, 10:464-8. 10.3816\/CLML.2010.n.080","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40320-5_14","article-title":"Bone disease in multiple myeloma","volume":"169","author":"Eda H","year":"2016","unstructured":"Eda H, Santo L, David Roodman G, Raje N. Bone disease in multiple myeloma. Cancer Treat Res. 2016, 169:251-70. 10.1007\/978-3-319-40320-5_14","journal-title":"Cancer Treat Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/196919-descriptive-characteristics-of-multiple-myeloma-patients-in-king-abdulaziz-medical-city-national-guard","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:13:48Z","timestamp":1707509628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/196919-descriptive-characteristics-of-multiple-myeloma-patients-in-king-abdulaziz-medical-city-national-guard"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,21]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.52692","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,21]]}}}